Company Filing History:
Years Active: 2018
Title: Hisashi Honma: Innovator in X-ray Fluorescence Spectrometry
Introduction
Hisashi Honma is a notable inventor based in Takatsuki, Japan. He has made significant contributions to the field of X-ray fluorescence spectrometry, holding 2 patents that enhance the capabilities of analytical instruments. His work is instrumental in advancing quantitative analysis techniques.
Latest Patents
Honma's latest patents include innovative designs for X-ray fluorescence spectrometers. The first patent describes a quantitative analysis condition setting unit that performs qualitative analyses of multiple standard samples. This unit sets peak measurement angles for analytical samples based on qualitative analysis results and synthesizes peak profiles to create a virtual profile for improved accuracy in quantitative analysis. The second patent outlines a scanning-type X-ray fluorescence spectrometer that determines whether to add new detected elements as analytical elements. This decision is based on the absorption-enhancement effect of fluorescent X-rays and the overlapping effect of interfering lines, utilizing qualitative and semi-quantitative analysis results from standard samples.
Career Highlights
Hisashi Honma is associated with Rigaku Corporation, a leading company in analytical and measurement instruments. His work at Rigaku has positioned him as a key player in the development of advanced spectrometric technologies. His contributions have been vital in enhancing the precision and efficiency of analytical processes.
Collaborations
Honma has collaborated with esteemed colleagues such as Shinya Hara and Takashi Matsuo. These partnerships have fostered innovation and have been crucial in the successful development of his patented technologies.
Conclusion
Hisashi Honma's work in X-ray fluorescence spectrometry exemplifies the impact of innovation in analytical science. His patents reflect a commitment to improving measurement techniques, which benefits various scientific and industrial applications.